ألفابرنزيما

  • Composition

Each 1 mL of suspension contains 10 mg of brinzolamide and 2 mg of brimonidine tartrate, preserved with 0.06 mg Benzalkonium chloride.

  • Indications

Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.

  • How supplied

5 ml dropper bottle.

Read More

en_USEnglish
No products in the cart.